These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 494660

  • 21. Activity of liver microsomal mono-oxygenases on some epoxide-forming cyclic tricyclic drugs. I. Kinetics in vitro.
    Pachecka J, Salmona M, Cantoni L, Mussini E, Pantarotto C, Frigerio A, Belvedere G.
    Xenobiotica; 1976 Oct; 6(10):593-8. PubMed ID: 983116
    [Abstract] [Full Text] [Related]

  • 22. Metabolism of the epoxy resin component 2,2-bis[4-(2,3-epoxypropoxy)phenyl]propane, the diglycidyl ether of bisphenol A (DGEBPA) in the mouse. Part II. Identification of metabolites in urine and faeces following a single oral dose of 14C-DGEBPA.
    Climie IJ, Hutson DH, Stoydin G.
    Xenobiotica; 1981 Jun; 11(6):401-24. PubMed ID: 7293231
    [Abstract] [Full Text] [Related]

  • 23. Biotransformation of N-methylcyclobarbital in vivo in rabbit and rat.
    Miyano K, Shimodouzono Y, Toki S.
    Xenobiotica; 1985 May; 15(5):381-9. PubMed ID: 2863899
    [Abstract] [Full Text] [Related]

  • 24. The metabolism of a chlorinated epoxide (MME): diol formation by pig liver microsomes.
    Forrest TJ, Walker CH, Hassall KA.
    Biochem Pharmacol; 1979 Mar 15; 28(6):859-65. PubMed ID: 454483
    [No Abstract] [Full Text] [Related]

  • 25. Stereoselective formations of K-region and non-K-region epoxides in the metabolism of chrysene by rat liver microsomal cytochrome P-450 isozymes.
    Yang SK, Bao ZP.
    Mol Pharmacol; 1987 Jul 15; 32(1):73-80. PubMed ID: 3037304
    [Abstract] [Full Text] [Related]

  • 26. The biotransformation of 1-hexadecene to carcinogenic 1,2-epoxyhexadecane by hepatic microsomes.
    Watabe T, Yamada N.
    Biochem Pharmacol; 1975 May 01; 24(9):1051-3. PubMed ID: 1156447
    [No Abstract] [Full Text] [Related]

  • 27. Metabolites of 1,2-epoxy-3-phenoxy- and 1,2-epoxy-3-(p-nitrophenoxy)propane.
    James SP, Pheasant AE, Solheim E.
    Xenobiotica; 1978 Apr 01; 8(4):219-28. PubMed ID: 645105
    [Abstract] [Full Text] [Related]

  • 28. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
    Wood AW, Chang RL, Levin W, Kumar S, Shirai N, Jerina DM, Lehr RE, Conney AH.
    Cancer Res; 1986 Jun 01; 46(6):2760-6. PubMed ID: 3516386
    [Abstract] [Full Text] [Related]

  • 29. Metabolism and mutagenicity of styrene and styrene oxide.
    Vainio H, Norppa H, Belvedere G.
    Prog Clin Biol Res; 1984 Jun 01; 141():215-25. PubMed ID: 6718374
    [No Abstract] [Full Text] [Related]

  • 30. Epoxides as obligatory intermediates in the metabolism of alpha-halohydrins.
    Jones AR, Fakhouri G.
    Xenobiotica; 1979 Oct 01; 9(10):595-9. PubMed ID: 532212
    [Abstract] [Full Text] [Related]

  • 31. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW, Wislocki PG, Chang RL, Levin W, Lu AY, Yagi J, Hernandez O, Herina DM, Conney AH.
    Cancer Res; 1976 Sep 01; 36(9 pt.1):3358-66. PubMed ID: 788899
    [Abstract] [Full Text] [Related]

  • 32. Tumorigenicity studies with diol-epoxides of benzo(a)pyrene which indicate that (+/-)-trans-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene is an ultimate carcinogen in newborn mice.
    Kapitulnik J, Wislocki PG, Levin W, Yagi H, Jerina DM, Conney AH.
    Cancer Res; 1978 Feb 01; 38(2):354-8. PubMed ID: 620406
    [Abstract] [Full Text] [Related]

  • 33. Metabolic transformation of clinically used drugs to epoxides: new perspectives in drug-drug interactions.
    Oesch F.
    Biochem Pharmacol; 1976 Sep 01; 25(17):1935-7. PubMed ID: 985529
    [No Abstract] [Full Text] [Related]

  • 34. Benzofluoranthenes: calculated diol epoxide reactivities.
    Silverman BD, Lowe JP.
    Chem Biol Interact; 1983 Dec 01; 47(3):289-92. PubMed ID: 6652812
    [Abstract] [Full Text] [Related]

  • 35. Formation of stable epoxides in the metabolism of tricyclic drugs.
    Frigerio A, Cavo-Briones M, Belvedere G.
    Drug Metab Rev; 1976 Dec 01; 5(2):197-218. PubMed ID: 802468
    [No Abstract] [Full Text] [Related]

  • 36. Uptake, metabolism and mutagenic activity of aromatic glycidyl compounds.
    Seiler JP.
    Chem Biol Interact; 1984 Oct 01; 51(3):347-56. PubMed ID: 6386198
    [Abstract] [Full Text] [Related]

  • 37. Epoxide to olefin: a novel biotransformation in the rumen.
    Ivie GW.
    Science; 1976 Mar 05; 191(4230):959-61. PubMed ID: 1251209
    [Abstract] [Full Text] [Related]

  • 38. The metabolism of n-butyl glycidyl ether in the rat and rabbit.
    Eadsforth CV, Hutson DH, Logan CJ, Morrison BJ.
    Xenobiotica; 1985 Jul 05; 15(7):579-89. PubMed ID: 4049898
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Age-dependent differences in the effect of phenprocoumon on the vitamin K1-epoxide cycle in rats.
    Trenk D, Beermann D, Oesch F, Jähnchen E.
    J Pharm Pharmacol; 1980 Dec 05; 32(12):828-32. PubMed ID: 6110746
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.